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INTRODUCTION 
 
Plants have been widely known as major sources of anticancer; 
but, their roles as an anticoagulant are still questionable. On the 
other hand, animals are the biggest suppliers of anticoagulant of 
all times; yet, the halal status of the animal-derived products is a 
major concern for the Muslim community. Glycosaminoglycans 
(GAGs) are compounds that have medicinal properties such as 
anticoagulant and anticancer. Currently, the main sources of 
GAGs are from animals, especially swine. This brings a big issue 
especially for the Muslim community to consume and use 
medicinal products with ingredients derived from porcine 
sources. The good news is that GAGs can also be isolated from 
plants. However, very few studies have reported the properties of 
GAGs from plant sources. Thus, this article reviews GAGs 
isolated from plants as a source of anticoagulant and anticancer.  
 
Medicinal plants as sources for treatments 
 
As they contain therapeutic compounds, plants have long become 
primary medicinal sources. In fact, humans rely on the 
effectiveness of plants to cure themselves from many medical 
conditions such as diarrhoea [1], acne [2], respiratory problem, 
and wound [3]. Scientists have conducted studies to investigate 
the biological functions of plants. For example, a study has 
experimentally proven an antituberculosis potential of Malaysian 
traditional plants [4]. In the study, tetrazolium microplate assay 
was carried out, and four plant species were found to have an 
active component that inhibited tuberculosis, namely Costus 
speciosus, Piper sarmentosum, Pluchea indica (from leaf and 
flower, separately), and Tabernaemontana coronaria. In another 
study, Pereskia bleo was found to be able to induce apoptosis in 
breast carcinoma [5]. This result was in agreement with [6], 
which showed a cytotoxic activity of P. bleo on cancer cells.  
 
Other than that, a study has reported that almost 80% of 
Ethiopian people depended on traditional medicines from plant 
origins [7]. The study investigated the lifestyle of Zay people in 
consuming medicines made from plants. Thirty-three types of 
plants were evaluated as to which ones were the most preferred 
by the Zay people based on their knowledge on medicinal plants, 
factors affecting the practice, current status/abundance of 
medicinal plants, and possible threats in the area. All the plants 
in the study were reported to have their own functions in healing 
illnesses such as gastrointestinal problems, febrile ailments, skin 
diseases, chest pain, and other common illnesses like 
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 ABSTRACT 
Glycosaminoglycans (GAGs) are usually found in mammals or invertebrates organisms. Since 
there are many potential active ingredients in plants that have not been investigated till dates, this 
review will be discussing the plants’ potential to be the alternative for GAGs source. The study 
will enlighten the correlation between two crucial properties, anticoagulant and anticancer 
properties. This is because these two properties are usually found in organisms with GAGs 
presence. GAGs have obviously played an important role to elicit these two properties within an 
organism’s biological system. The study found that based on previous researches investigations, 
plants have the potential to have GAGs which then act as replacement of anticoagulant carrying 
anticancer properties. 
KEYWORDS  Glycosaminoglycans medicinal plants anticancer anticoagulant 
 
 
JOURNAL OF BIOCHEMISTRY, MICROBIOLOGY 
AND BIOTECHNOLOGY 
 
Website: http://journal.hibiscuspublisher.com/index.php/JOBIMB/index 
 
JOBIMB VOL 7 NO 1 2019 
Per ARNT SIM Domain Gene distribution in  
normal human testis cell 
JOBIMB, 2019, Vol 7, No 1, 52-55 
 
- 53 - 
 
haemorrhoids, tonsillitis, and toothache. The study has proven 
that the plants carried all sorts of healing abilities not only for 
humans, but for animals as well.  
 
Anticoagulant and anticancer 
 
An anticoagulant, as the name implies, prevents coagulation 
mechanism. As defined by the American Heart Association, an 
anticoagulant stops any actions or factors that are required for 
coagulation to happen by blocking a protein called a cofactor, 
which is classified into thrombin and fibrin. The cofactor 
production is controlled by vitamin K in the liver. Warfarin (a 
type of anticoagulant) also controls the production of the 
cofactor. Thrombin and fibrin work together to make the blood 
components to clot. An anticoagulant such as heparin stops the 
actions of thrombin and fibrin. Therefore, warfarin and heparin 
play important roles to ensure blood clotting can be regulated. 
Warfarin and heparin are produced from a single compound 
named glycosaminoglycans (GAGs), which can be found in 
diverse forms and sources.  
 
Previous researches have investigated the potential 
medicinal properties of certain compounds from plant samples. 
The Western medicinal studies have been focusing on isolation 
and identification of one compound from a sample. However, this 
approach has been disapproved by a study that observed the 
cytoprotective and antioxidant properties of Chinese medicinal 
herbs [8]. The researchers concluded that the use of only one 
compound in a treatment might lead to an imbalance between 
body and environment, which could in turn cause diseases.  
 
Such a conclusion is in line with another study on traditional 
Chinese medicine for cancer treatments [9]. The researchers 
investigated 50 types of plant that were proven to carry an 
anticancer property. They found a high amount of phenolic 
compound in these plants, which also exhibited a high 
antioxidant activity. Not only that, a phenolic compound named 
coumarin (vitamin K antagonist) that reduces blood clotting by 
preventing vitamin K production, was also found in these plants. 
The researchers concluded that the total phenol content in the 
plants reflected their antioxidant activity, and reflected the role 
of these plants as an anticancer and anticoagulant. Therefore, it 
is possible to test multiple medicinal properties of plants, as one 
property might be caused or supported by another property.  
 
GAGs as anticancer and anticoagulant 
 
Glycosaminoglycans are divided into several classes such as 
heparan sulphate, chondroitin sulphate, keratan sulphate, and 
hyaluronic acid (see Fig. 1). These classes have different 
functions [10-13]. Of all these classes, heparan sulphate is said to 
have numerous anticoagulant contents. The structure of heparin 
and chondroitin are completely identical, but their anticoagulant 
abilities are different [14].  
 
A previous study has discussed the action of heparin to avert 
tumour cells. According to the study, chondroitin sulphate carries 
much lower anticoagulant than heparin [15]. Heparin sulphate 
contains heparin (highly negative charge than heparan sulphate) 
in human body in heparan sulphate proteoglycan. Fibrin is a 
component responsible for coagulation to occur. It protects 
tumour cells by surrounding them. This so-called heparin, on the 
other hand, carries a predominant role in atherogenesis. It helps 
to break open the tumour cells’ protective zone by inducing them 
to be susceptible to natural killer cells. This is how an 
anticoagulant affects cancer activity. 
 
Moreover, heparin affects cancer progression in many ways 
[14]. Heparin-treated rats were found to be able to inhibit a 
metastatic process after administered with Walker carcinoma 
cells [16]. Heparin was also found to reduce tumour growth in 
induced rats [14, 17]. Another study has proven heparin was 
capable to alter the distribution patterns of cancer cells [18]. 
Heparin has also been demonstrated to have the capacity to affect 
the development of primary tumours and metastases and to 
prevent the development of thromboembolic events [19]. 
 
GAGs as an anticoagulant  
 
Studies have been conducted to investigate the ability of GAGs 
as an anticoagulant agent from various sources. For example, 
shrimp heparin from Penaeus brasiliensis was found to exhibit a 
similar antithrombotic activity like that of low molecular weight 
heparins. The shrimp species was found to be rich in glucuronic 
acid and non-sulphated iduronic acid residue [20]. Another 
example is an algae species as a source of anticoagulant. From a 
metachromatic assay, the algae species yielded 2.3g/50g yield of 
heparin, making the species a new anticoagulant agent. The algae 
species was found to resemble a heparin activity [21].  
 
Moreover, GAGs have also been extracted from snail. 
However, previously the method was tedious, thus researchers 
have come out with a novel and practical way to obtain a high 
and readily available yield. These acharan sulphate-like GAGs 
are highly effective at low concentrations such as 1 mg/mL and 
2 mg/mL. Other than that, GAGs have also been found in sea 
cucumber for thrombosis prevention by fucosylated chondroitin 
sulphate (FCS) [22]. At 1.5 mg/kg dose, FCS may reduce 
thrombosis rate. The anticoagulant activity is influenced by 
GAGs by intervening the venous thrombosis.  
 
Plants are highly believed to possess an anticoagulant 
property as they also contain anticancer agents. For example, 
Erigeron canadensis L. was found to act as an anticoagulant and 
antiplatelet due to its polyphenolic-polysaccharide activity [23]. 
The plant showed a higher anticoagulant activity than Porana 
volubilis [24]. Next, an anticoagulant from the plant Bauhinia 
forficata was reported to be the next cure for snake venom [25]. 
Other than that, GAGs in aloe vera such as Portulaca oleracea L. 
were found to be highly potential in healing wounds [26-28]. 
 
GAGs as an anticancer 
 
Glycosaminoglycans have been proven to have an anticancer 
activity. For example, a study on ovary cancer reported that 
GAGs were able to surpass a major obstacle in chemotherapy 
namely drug resistance by providing resistance towards 
mediators like P-glycoprotein and ATP-binding cassette [29]. 
Another study involving GAGs proposed heparosan-DOX 
conjugate in their attempt to investigate endocytosis pathway of 
heparosan on HeLa and A549 cells [30]. Other than that, there 
was also a new discovery on a methodology to mediate 
antiangiogenic acharan sulphate-like GAGs from one of its 
classes, heparin for cancer treatment. About 60% of clinical 
anticancer drugs originate from natural sources, mostly derived 
from plants [31]. Plants have long been used in the treatment of 
cancers [31,32]. Plants such as vegetables, fruits, and herbs are 
also used to treat cancer patients undergoing chemotherapy [33]. 
Remedies derived from natural products have been reported to 
help patients to endure their pain much better. Herbal 
preparations for treating cancers are more practical than 
conventional medicine especially for rural and poor people as 
they could get the medication at an affordable price 
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Fig. 1. Structure of different GAGs classes. Unlabelled sections indicate 
Hydrogen group.  
 
Plants are the best anticancer due to the presence of 
secondary metabolites that effectively block metabolic pathways 
and hormones that are direct or indirectly involved with cancer 
[34]. Ancient people believed plants were the best source of 
anticancer to prevent cancer diseases in many ways. However, 
their claims have not been proven scientifically. Thus, many 
clinical studies have been conducted by the reputable scientists 
to prove the claims. For example, Pouzolzia indica was found to 
exhibit the highest cytotoxic activity and to prevent cell 
mitochondrial activity of cancer cells [35]. Another study 
focusing on plant secondary metabolite reported many anticancer 
agents were derived from plant secondary metabolites [35]. 
Anticancer agents such as vinca alkaloids have been identified 
from Catharanthus roseus, Podophyllum sp., Taxus brevifolia, 
Camptotheca acuminate, Betula alba, Cephalotaxus sp., 
Erythroxylum pervillei, Curcuma longa, Ipomoea batatas, and 
Centaurea schischkinii.  
 
Many other clinical studies have proven the capability of 
plants in fighting against cancers. Examples are Ailanthus 
altissima and Pyrus malus against intestinal cancer, Chelidonium 
majus var. asiaticum against stomach cancer, Chimaphila 
umbellata against breast cancer, Lonicera japonica against 
ascites cancer, Nidus vespae against gastric and liver cancers, 
Oldenlandia diffusa against leukaemia, Phaleria macrocarpa 
against oesophageal cancer, Pygeum africanum against prostate 
cancer, and Vitex rotundifolia against lung tumour [23-25, 36-
40]. 
Anticancer property has been studied from diverse sources such 
as microorganisms, seafood, seafood waste, and animals. Such a 
property has also been studied on plants mostly from their 
secondary metabolite compounds. In most cases, the compounds 
have been tested on mammals for anticancer their effect. For 
example, the effect of heparin in an anticancer therapy on animal 
tumour model was investigated. The anticoagulant activity was 
found to show a good sign of inhibition in blood coagulation [41]. 
Cancer proliferation on cell lines was also observed to be 
inhibited by GAGs in osteoblasts and human osteosarcoma cells 
[42]. Heparin has also been identified as one of the GAGs for 
cancer therapy [43]. The activity of heparin on breast cancer was 
monitored. It was used as a biomarker for invasive ductal 
carcinoma. Other than that, GAGs are promising compounds to 
be modified. The effects of modified and pure chondroitin 
sulphates were compared, and it was found that they showed 
different effect on anticancer activity [44]. For example, heparin 
and chondroitin sulphate were mixed to secrete neoglycans, 
which were surprisingly effective to cause apoptosis to myeloma 
cells [45]. 
 
CONCLUSION 
 
Many studies have been carried out to investigate the potential of 
plants as a source of anticoagulant and anticancer. More 
investigations must be conducted to support previous pre-clinical 
studies, as plants could be a new source of anticoagulant carrying 
anticancer property, a potential that could replace animal-derived 
medications.  
 
ACKNOWLEDGMENT 
 
The authors would like to acknowledge Universiti Malaysia 
Pahang for the operation research grant (UMP-RDU130308) and 
the Ministry of Higher Education for the Research Acculturation 
Grant Scheme (RAGS RDU 131406) and Fundamental Research 
Grant (FRGS RDU 140131).  
  
REFERENCES 
 
1. Shoba FG, Thomas M. Study of antidiarrhoeal activity of four Med 
Plant in castor-oil induced diarrhoea. J Ethnopharmacol. 
2001;76(1):73-6. 
2. Rios J, Recio M. Med Plant and antimicrobial activity. J 
Ethnopharmacol. 2005;100(1):80-4. 
3. Tetik F, Civelek S, Cakilcioglu U. Traditional uses of some Med 
Plant in Malatya (Turkey). J Ethnopharmacol. 2013;146(1):331-46. 
4. Mohamad S, Zin NM, Wahab HA, Ibrahim P, Sulaiman SF, 
Zahariluddin ASM, et al. Antituberculosis potential of some 
ethnobotanically selected Malaysian plants. J Ethnopharmacol. 
2011;133(3):1021-6. 
5. Tan M, Sulaiman S, Najimuddin N, Samian M, Muhammad TT. 
Methanolic extract of Pereskia bleo (Kunth) DC.(Cactaceae) 
induces apoptosis in breast carcinoma, T47-D cell line. J 
Ethnopharmacol. 2005;96(1):287-94. 
6. Malek SNA, Shin SK, Wahab NA, Yaacob H. Cytotoxic 
components of Pereskia bleo (Kunth) DC.(Cactaceae) leaves. 
Molecules. 2009;14(5):1713-24. 
7. Birhan W, Giday M, Teklehaymanot T. The contribution of 
traditional healers’ clinics to public health care system in Addis 
Ababa, Ethiopia: a cross-sectional study. J Ethnobiol Ethnomed. 
2011;7:39. 
8. Steele ML, Truong J, Govindaraghavan S, Ooi L, Sucher NJ, 
Münch G. Cytoprotective properties of traditional Chinese 
medicinal herbal extracts in hydrogen peroxide challenged human 
U373 astroglia cells. Neurochem Int. 2013;62(5):522-9. 
9. Cai Y-Z, Sun M, Xing J, Luo Q, Corke H. Structure–radical 
scavenging activity relationships of phenolic compounds from 
traditional Chinese Med Plant. Life Sci. 2006;78(25):2872-88. 
10. Azmi NS, Fernig DG. Heparan Sulfate Surfaces to Probe the 
Functions of the Master Regulator of the Extracellular Space. In: 
Knoll W, editor. Handbook of Biofunctional Surfaces: Pan Stanford 
Publishing; 2013. p. 591-615. 
NHCOCH3
OH
OH
HO
O
O O
ß
KERATAN 
SULPHATE
O
O O
ß
O
OH
OH
COOH CH2OH
O
S
HO
NHCOCH3
O
CHONDROITIN 
SULPHATE
O
O O
Α
OH
COOH
CH2OH
OH
O
OSO3H NHOSO3
HEPARIN
O
O O
ß
OH
COOH CH2OH
O
HO
CH2OH CH2OSO3H
HYALURONATE
JOBIMB, 2019, Vol 7, No 1, 52-55 
 
- 55 - 
 
11. Zahari C, Azmi NS. Halal source of medication: 
glycosaminoglycan derived medicinal plant. Int J App Chem. 
2016;12(4):803-10. 
12. Marina MS, Azmi NS, Hasbi M, Rahim A. Review: 
Glycosaminoglycans (GAGs) Versus Cancer. J Environ Bioremed 
Toxicol. 2014;2(2):58-61. 
13. Idrus. NH AN, Palliah. JV. Waste To Wealth: Alternative Source 
Of Glycosaminoglycans (GAGS) From Sea Food Waste. Ins Integ 
Omics App Biotechnol J. 2016;7:543 - 7. 
14. Smorenburg SM, Van Noorden CJ. The complex effects of heparins 
on cancer progression and metastasis in experimental studies. 
Pharmacol Rev. 2001;53(1):93-106. 
15. Engelberg H. Actions of heparin that may affect the malignant 
process. Cancer. 1999;85(2):257-72. 
16. Fisher B, Fisher ER. Experimental studies of factors which 
influence hepatic metastases. VIII. Effect of anticoagulants. 
Surgery. 1961;50(1):240-7. 
17. Kim U. Factors influencing metastasis of breast cancer.  Curr 
Topics: Springer; 1979. p. 1-49. 
18. Hagmar B, Norrby K. Evidence for effects of heparin on cell 
surfaces influencing experimental metastases. Int J Cancer. 
1970;5(1):72-84. 
19. Bobek V, Kovařík J. Antitumor and antimetastatic effect of 
warfarin and heparins. Biomed Pharmaco. 2004;58(4):213-9. 
20. Dietrich CP, Paiva JF, Castro RA, Chavante SF, Jeske W, Fareed J, 
et al. Structural features and anticoagulant activities of a novel 
natural low molecular weight heparin from the shrimp Penaeus 
brasiliensis. Biochim et Biophys Acta (BBA)-General Subjects. 
1999;1428(2):273-83. 
21. Ganesh EA. Heparin like Compound from Green Alga 
Chaetomorpha antennina As Potential Anticoagulant Agent. Asian 
J Med Sci 2009.1(3): 114-116 
22. Pomin VH. NMR chemical shifts in structural biology of 
glycosaminoglycans. Anal Chem. 2013;86(1):65-94. 
23. Faried A, Kurnia D, Faried L, Usman N, Miyazaki T, Kato H, et al. 
Anticancer effects of gallic acid isolated from Indonesian herbal 
medicine, Phaleria macrocarpa (Scheff.) Boerl, on human cancer 
cell lines. Int J Oncol. 2007;30(3):605-13. 
24. Pawlaczyk I, Czerchawski L, Kuliczkowski W, Karolko B, Pilecki 
W, Witkiewicz W, et al. Anticoagulant and anti-platelet activity of 
polyphenolic-polysaccharide preparation isolated from the 
medicinal plant Erigeron canadensis L. Thrombosis Res. 
2011;127(4):328-40. 
25. Yoon S-J, Pereira MS, Pavão MS, Hwang J-K, Pyun Y-R, Mourão 
PA. The medicinal plant Porana volubilis contains polysaccharides 
with anticoagulant activity mediated by heparin cofactor II. 
Thrombosis Res2002;106(1):51-8. 
26. Oliveira CZ, Maiorano VA, Marcussi S, Sant’Ana CD, Januário 
AH, Lourenço MV, et al. Anticoagulant and antifibrinogenolytic 
properties of the aqueous extract from Bauhinia forficata against 
snake venoms. J Ethnopharmacol. 2005;98(1-2):213-6. 
27. Chithra P, Sajithlal G, Chandrakasan G. Influence of Aloe vera on 
the glycosaminoglycans in the matrix of healing dermal wounds in 
rats. J Ethnopharmacol. 1998;59(3):179-86. 
28. Rahmani N, Khademloo M, Vosoughi K, Assadpour S. Effects of 
Aloe vera cream on chronic anal fissure pain, wound healing and 
hemorrhaging upon defection: a prospective double blind clinical 
trial. Eur Rev Med Pharmacol Sci. 2014;18(7):1078-84. 
29. Cohen K, Emmanuel R, Kisin-Finfer E, Shabat D, Peer D. 
Modulation of drug resistance in ovarian adenocarcinoma using 
chemotherapy entrapped in hyaluronan-grafted nanoparticle 
clusters. ACS Nano. 2014;8(3):2183-95. 
30. Chen J-X, Liu W, Zhang M, Chen J-H. Heparosan based negatively 
charged nanocarrier for rapid intracellular drug delivery. Int J 
Pharma. 2014;473(1):493-500. 
31. Cragg GM, Newman DJ. Plants as a source of anti-cancer agents. J 
Ethnopharmacol. 2005;100(1-2):72-9. 
32. Graham RA, Li T, Cooke ID, Aplin JD. Keratan sulphate as a 
secretory product of human endometrium: cyclic expression in 
normal women. Human Reprod. 1994;9(5):926-30. 
33. Newman DJ, Cragg GM, Snader KM. Natural products as sources 
of new drugs over the period 1981− 2002. J Nat Prod. 
2003;66(7):1022-37. 
34. Nirmala MJ, Samundeeswari A, Sankar PD. Natural plant resources 
in anti-cancer therapy-A review. Research in Plant Biology. 
2011;1(3). 
35. Amri E. The role of selected plant families with dietary 
Ethnomedicinal species used as anticancer. J Med Plant. 2014;2(1). 
36. Han Y, Liu Y, Nie L, Gui Y, Cai Z. Inducing cell proliferation 
inhibition, apoptosis, and motility reduction by silencing long 
noncoding ribonucleic acid metastasis-associated lung 
adenocarcinoma transcript 1 in urothelial carcinoma of the bladder. 
Urology. 2013;81(1):209. e1-. e7. 
37. Powell CB, Fung P, Jackson J, Dall'Era J, Lewkowicz D, Cohen I, 
et al. Aqueous extract of herba Scutellaria barbatae, a Chinese herb 
used for ovarian cancer, induces apoptosis of ovarian cancer cell 
lines. Gynecol Oncol. 2003;91(2):332-40. 
38. Geffen JR. The Journey Through Cancer: An Oncologist's Seven-
level Program for Healing and Transforming the Whole Person: 
Crown Publishers New York; 2000. 
39. Setyawan AD. Traditionally utilization of Selaginella; field 
research and literature review. Bioscience. 2009;1(3):146-58. 
40. Sinclair S. Chinese herbs: a clinical review of Astragalus, 
Ligusticum, and Schizandrae. Alt Med Rev. 1998;3:338-44. 
 
